© AS Photo Family / Adobe Stock
Newborns are usually not included in clinical trials for the development of antimicrobial drugs, which means there is very little information on how these drugs
Engaging key stakeholders, including clinical staff, families, communities, parent support groups, regulators and ethics experts, is crucial for the success of trials with novel or
On 30-31 January 2024, partners in the SNIP-AFRICA project came together in Johannesburg, South Africa, for their first in-person meeting which formally kicks off project
Johannesburg, South Africa, 30th January 2024 – This week, expert scientists and clinicians from PediCAP and SNIP-AFRICA, two major research partnerships combatting antimicrobial resistance, convene
In an era marked by increasing antimicrobial resistance, which threatens the effectiveness of commonly used antibiotic treatments for childhood infections and sepsis, projects like SNIP-AFRICA
On 20 September 2023, the Global Antibiotic Research & Development Partnership (GARDP) hosted a REVIVE webinar focusing on clinical trial platforms for new and neglected
Padova (Italy), 27 July 2023 – A new European-African collaboration to improve the way infections in newborns are treated is launching today. The project, called SNIP-AFRICA,
